Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cannapharmarx Inc (OP: CPMD )

0.0085 UNCHANGED
Streaming Delayed Price Updated: 3:55 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,166,497
Open 0.0095
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0085
Today's Range 0.0052 - 0.0095
52wk Range 0.0052 - 0.0261
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CannaPharmaRx Signs Agreement with Nasha Genetics
Via ACCESSWIRE
CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis
CannaPharmaRx, Inc. (OTCPK:CPMD) has signed a supply agreement with Israeli company Y.S.A Holdings. The business arrangement sets forth a supply agreement between the two companies. 
Via Benzinga

Performance

YTD
-22.02%
-22.02%
1 Month
-7.61%
-7.61%
3 Month
+8.97%
+8.97%
6 Month
+6.25%
+6.25%
1 Year
-24.78%
-24.78%

More News

Read More
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
Via ACCESSWIRE
New Leaf Ventures Enters Into Genetics Supply Agreement With CannaPharmaRX
Via Benzinga
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
Via ACCESSWIRE
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
Via ACCESSWIRE
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
Via ACCESSWIRE
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
Via ACCESSWIRE
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Via ACCESSWIRE
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
Via Newsfile
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Via ACCESSWIRE
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Cannabis Cultivation Revenue Continues to Climb as Demand & Usage Grows Across North America
Via FinancialNewsMedia
Topics Cannabis Derivatives
Exposures COVID-19 Cannabis Derivatives
CannaPharmaRx Secures New Strains for Declaration to be Incorporated Into Product Portfolio
Via ACCESSWIRE
CannaPharmaRx Files Response with Health Canada in Preparation for Cremona Facility Opening
Via ACCESSWIRE
CannaPharmaRx Signs Collaboration and Offtake Agreement with Spring Medical Group for Up to $12 Million of Commercial Cannabis
Via ACCESSWIRE
CannaPharmaRx Enters into a Genetics Transfer Agreement with High Profile Cannabis Corp.
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Acquiring Oklahoma Cannabis Facility
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Stops Issuing Shares Under Previously Effective S-1
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to Market
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis Product
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/Year
From CannaPharmaRx
Via AccessWire
Topics Cannabis
Exposures Cannabis
CannaPharmaRX, Inc. Closes Sale of Hanover Facility for $2,000,000 CAD
From CannaPharmaRx
Via AccessWire
Topics Cannabis Energy
Exposures Cannabis Electricity Generation
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.